Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
GO:0005787 | signal peptidase complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0098796 | membrane protein complex | 2 | 1 |
GO:0140534 | endoplasmic reticulum protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1905368 | peptidase complex | 3 | 1 |
Related structures:
AlphaFold database: A4HRF5
Term | Name | Level | Count |
---|---|---|---|
GO:0006465 | signal peptide processing | 5 | 1 |
GO:0006508 | proteolysis | 4 | 1 |
GO:0006518 | peptide metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0016485 | protein processing | 5 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043603 | amide metabolic process | 3 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0051604 | protein maturation | 4 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0008233 | peptidase activity | 3 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 128 | 130 | PF00675 | 0.389 |
CLV_PCSK_SKI1_1 | 129 | 133 | PF00082 | 0.365 |
CLV_PCSK_SKI1_1 | 30 | 34 | PF00082 | 0.396 |
CLV_PCSK_SKI1_1 | 54 | 58 | PF00082 | 0.287 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.330 |
DOC_MAPK_FxFP_2 | 187 | 190 | PF00069 | 0.523 |
DOC_MAPK_gen_1 | 129 | 138 | PF00069 | 0.518 |
DOC_MAPK_gen_1 | 74 | 82 | PF00069 | 0.376 |
DOC_MAPK_MEF2A_6 | 132 | 140 | PF00069 | 0.503 |
DOC_PP4_FxxP_1 | 163 | 166 | PF00568 | 0.612 |
DOC_PP4_FxxP_1 | 187 | 190 | PF00568 | 0.506 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.647 |
DOC_USP7_MATH_1 | 203 | 207 | PF00917 | 0.547 |
DOC_WW_Pin1_4 | 161 | 166 | PF00397 | 0.580 |
LIG_14-3-3_CanoR_1 | 139 | 145 | PF00244 | 0.547 |
LIG_14-3-3_CanoR_1 | 18 | 28 | PF00244 | 0.521 |
LIG_14-3-3_CanoR_1 | 30 | 39 | PF00244 | 0.546 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.673 |
LIG_BRCT_BRCA1_1 | 159 | 163 | PF00533 | 0.580 |
LIG_BRCT_BRCA1_1 | 183 | 187 | PF00533 | 0.606 |
LIG_BRCT_BRCA1_1 | 83 | 87 | PF00533 | 0.356 |
LIG_Clathr_ClatBox_1 | 149 | 153 | PF01394 | 0.484 |
LIG_EH1_1 | 74 | 82 | PF00400 | 0.241 |
LIG_FHA_1 | 111 | 117 | PF00498 | 0.530 |
LIG_FHA_1 | 20 | 26 | PF00498 | 0.555 |
LIG_FHA_1 | 31 | 37 | PF00498 | 0.523 |
LIG_FHA_1 | 96 | 102 | PF00498 | 0.491 |
LIG_FHA_2 | 2 | 8 | PF00498 | 0.610 |
LIG_GBD_Chelix_1 | 93 | 101 | PF00786 | 0.221 |
LIG_LIR_Apic_2 | 160 | 166 | PF02991 | 0.614 |
LIG_LIR_Apic_2 | 184 | 190 | PF02991 | 0.517 |
LIG_LIR_Gen_1 | 153 | 162 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 153 | 157 | PF02991 | 0.550 |
LIG_LIR_Nem_3 | 175 | 181 | PF02991 | 0.526 |
LIG_LIR_Nem_3 | 38 | 42 | PF02991 | 0.583 |
LIG_LIR_Nem_3 | 84 | 89 | PF02991 | 0.334 |
LIG_MLH1_MIPbox_1 | 83 | 87 | PF16413 | 0.275 |
LIG_PCNA_yPIPBox_3 | 194 | 208 | PF02747 | 0.591 |
LIG_SH2_NCK_1 | 169 | 173 | PF00017 | 0.540 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.512 |
LIG_SH2_STAT5 | 70 | 73 | PF00017 | 0.382 |
LIG_TYR_ITIM | 40 | 45 | PF00017 | 0.552 |
LIG_WW_1 | 166 | 169 | PF00397 | 0.393 |
MOD_CK2_1 | 1 | 7 | PF00069 | 0.589 |
MOD_CK2_1 | 167 | 173 | PF00069 | 0.450 |
MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.449 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.398 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.508 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.633 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.273 |
MOD_NEK2_1 | 181 | 186 | PF00069 | 0.498 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.424 |
MOD_NEK2_1 | 81 | 86 | PF00069 | 0.274 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.241 |
MOD_PIKK_1 | 120 | 126 | PF00454 | 0.611 |
MOD_PIKK_1 | 138 | 144 | PF00454 | 0.468 |
MOD_PIKK_1 | 167 | 173 | PF00454 | 0.554 |
MOD_PKA_2 | 114 | 120 | PF00069 | 0.429 |
MOD_PKA_2 | 138 | 144 | PF00069 | 0.407 |
MOD_PKA_2 | 75 | 81 | PF00069 | 0.275 |
MOD_Plk_1 | 172 | 178 | PF00069 | 0.473 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.545 |
MOD_Plk_4 | 82 | 88 | PF00069 | 0.340 |
MOD_Plk_4 | 97 | 103 | PF00069 | 0.412 |
MOD_ProDKin_1 | 161 | 167 | PF00069 | 0.463 |
MOD_SUMO_for_1 | 150 | 153 | PF00179 | 0.373 |
TRG_ENDOCYTIC_2 | 169 | 172 | PF00928 | 0.384 |
TRG_ENDOCYTIC_2 | 178 | 181 | PF00928 | 0.350 |
TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.439 |
TRG_ER_diLys_1 | 207 | 210 | PF00400 | 0.530 |
TRG_NLS_MonoExtN_4 | 126 | 133 | PF00514 | 0.426 |
TRG_Pf-PMV_PEXEL_1 | 129 | 134 | PF00026 | 0.447 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JMH0 | Bodo saltans | 30% | 77% |
A0A1X0P325 | Trypanosomatidae | 32% | 94% |
A0A3S5H4U6 | Leishmania donovani | 100% | 100% |
A0A3S5ISA1 | Trypanosoma rangeli | 27% | 92% |
A4H358 | Leishmania braziliensis | 75% | 100% |
C9ZXH9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 95% |
E9AC23 | Leishmania major | 94% | 100% |
E9AJC0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |